134 related articles for article (PubMed ID: 6410039)
1. Effects of N-(4-methylbenzylthiocarbonyl)-L-phenylalanine (KF 1492), a new hypolipidemic drug, and clofibrate on lipids metabolism.
Ishii A; Deguchi T; Marumo H; Tanaka M
J Pharmacobiodyn; 1983 Mar; 6(3):170-6. PubMed ID: 6410039
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-(4-methylbenzylthiocarbonyl)-L-phenylalanine (KF 1492), a new phenylalanine derivative on lipid synthesis in vivo, inhibition of hepatic cholesterol synthesis and 3-hydroxy-3-methylglutaryl-Co A reductase.
Ishii A; Deguchi T; Marumo H; Tanaka M
J Pharmacobiodyn; 1981 Dec; 4(12):933-9. PubMed ID: 7341749
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering effects of N-[4-methylbenzylthiocarbonyl]-L-phenylalanine (KF1492), a new phenylalanine derivative.
Yamada K; Shuto K; Kojima T; Marumo H; Tanaka M
J Pharmacobiodyn; 1982 Aug; 5(8):611-8. PubMed ID: 7153833
[TBL] [Abstract][Full Text] [Related]
4. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
5. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
Cuchet P; Morrier C; Cand F; Keriel C
Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
[TBL] [Abstract][Full Text] [Related]
6. Effect of clofibrate on cholesterol and lipid metabolism in ethanol - treated mice.
Rawat AK
Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):501-10. PubMed ID: 1135514
[TBL] [Abstract][Full Text] [Related]
7. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
Hall MJ; Nelson LM; Russell RI; Howard AN
Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
[TBL] [Abstract][Full Text] [Related]
9. The effects of cyclic imides on lipid absorption from the intestine and on bile lipids and bile acids of Sprague Dawley rats.
Hall IH; Reynolds DJ; Wong OT; Simlot S
Pharmacol Res; 1993; 27(2):129-39. PubMed ID: 8474958
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the lipid-lowering activity of AY-25,712 in rats.
Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
Atherosclerosis; 1982 Dec; 45(3):267-79. PubMed ID: 6818976
[TBL] [Abstract][Full Text] [Related]
11. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Turley SD; Dietschy JM
J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
[TBL] [Abstract][Full Text] [Related]
12. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
Kähönen MT; Ylikahri RH
Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
[TBL] [Abstract][Full Text] [Related]
13. Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.
Kutz K; Schulte A; Just C; Lindstaedt H; Reiter B
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):171-7. PubMed ID: 503248
[No Abstract] [Full Text] [Related]
14. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
Grundy SM
J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of aldehyde dehydrogenase activity in rat liver by clofibrate feeding.
Kramar R; Kremser K
Enzyme; 1984; 31(1):17-20. PubMed ID: 6714196
[TBL] [Abstract][Full Text] [Related]
16. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
[TBL] [Abstract][Full Text] [Related]
17. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
Maier R; Muller K
Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
[TBL] [Abstract][Full Text] [Related]
18. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
19. Major clofibrate effects on liver and plasma lipids are independent of changes in polyunsaturated fatty acid composition induced by dietary fat.
Pennacchiotti GL; Maldonado EN; Aveldaño MI
Lipids; 2001 Feb; 36(2):121-7. PubMed ID: 11269691
[TBL] [Abstract][Full Text] [Related]
20. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
